Analysts' ratings for Alkermes (NASDAQ: ALKS) over the last quarter vary from bullish to bearish, as provided by 9 analysts.

After this recent surge, is STX still a viable purchase – or is it time to secure profits? Dive deeper with Buy or Sell STX.

The advent of much lower corn and soybean market prices, together with reduced 2024 corn and soybean yields, has resulted in ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones ...

Saga plc ( OTCPK:SGPLF) Interim Results Investor Presentation Call ...

Corporate boards in the U.S. have never been more diverse. Those same boards are now hiring white guys at the fastest clip in ...

In addition, Seez has grown a stand-alone business by over 500 rooftops since it became part of Pinewood.AI, with new entries in North America as well as the U.K. Those stores will be fully ...

Hansa Biopharma A/S has turned in positive data from a pivotal U.S. phase III trial of imlifidase, an enzyme that speedily removes antibodies from the bloodstream, enabling highly sensitized kidney ...

Mural Oncology plc, (Nasdaq: MURA) (“Mural ”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 (the “Irish ...

Mural Oncology plc, (Nasdaq: MURA) ("Mural"), a clinical-stage immuno-oncology company, today announces for the purposes of the ...